Montelukast Prescribing at MORRIS HOUSE GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,351
Total Quantity
41.2K
NHS Cost
£2.0K
vs National Avg
+97.3%
MORRIS HOUSE GROUP PRACTICE prescribed 1,351 items of Montelukast over the last 12 months at a cost of £1,989 to the NHS. This is 97.3% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
115
Jul 2026
103
Jul 2026
124
Jul 2026
112
Jul 2026
115
Jul 2026
119
Jul 2026
131
Jul 2026
91
Jul 2026
130
Jul 2026
85
Jul 2026
123
Jul 2026
103
Prescribing Details
| Total Items | 1,351 |
|---|---|
| Total Quantity | 41,179 |
| Total NHS Cost | £1,989 |
| Presentations | 4 different forms |
| vs National Average | +97.3% |
Montelukast Prescribing Comparison
| This practice | 1,351 items |
|---|---|
| National average per practice | 685 items |
| Difference | +97.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.